Table 1.
Region of interest | Dose criteria | Limit* | Limit if the PTV overlaps non-liver normal tissues |
---|---|---|---|
GTV | Min to 0.5 cm3 | 95% of prescription | n/a |
PTVGTV† | Min (max) to 0.5 cm3 volume | 95% (140%) of prescription | 80% of prescription |
PTVCTV† | Min to 0.5 cm3 | 27.0 Gy | n/a |
Large Bowel | Max to 0.5 cm3 | 28.2 Gy | 30.0 Gy |
Small Bowel | Max to 0.5 cm3 | 28.2 – 33.6 Gy | 30.0 – 36.0 Gy |
Stomach | Max to 0.5 cm3 | 28.2 – 30.0 Gy | 30.0 – 33.6 Gy |
Duodenum, esophagus | Max to 0.5 cm3 | 28.2 Gy | 30.0 Gy |
Kidney(s) | Mean to one or combined kidneys | 10 Gy | n/a |
Abbreviations: GTV = gross tumor volume; CTV = clinical target volume (GTV plus 0.8 cm expansion in liver); PTV = planning target volume (patient specific internal margin for breathing plus 0.3 cm setup margin expansion); PTVGTV = PTV applied around the GTV; PTVCTV = PTV applied around the CTV.
Notes:
Ranges indicate criteria was modified during the course of the trial
For each patient the same PTV expansion was applied to each the GTV and CTV though dose criteria was different.